Asthma Patients' real experiences tracked in global treatment study

NCT ID NCT05603845

Summary

This study observed 291 patients with severe asthma who were prescribed benralizumab, a medication that reduces inflammation. Researchers tracked how patients' asthma control and quality of life changed over 56 weeks of treatment in real-world healthcare settings across multiple countries. The goal was to understand how this treatment works outside of controlled clinical trials and improve doctor-patient communication about asthma management.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SEVERE ASTHMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Bogotá, Colombia

  • Research Site

    Bucaramanga, Colombia

  • Research Site

    Ibagué, Colombia

  • Research Site

    Pereira, Colombia

  • Research Site

    Santiago de los Caballeros, Dominican Republic

  • Research Site

    Santo Domingo, Dominican Republic

  • Research Site

    Ahmedabad, India

  • Research Site

    Ajmer, India

  • Research Site

    Chennai, India

  • Research Site

    Delhi, India

  • Research Site

    Hyderabad, India

  • Research Site

    Jaipur, India

  • Research Site

    Kolkata, India

  • Research Site

    Pune, India

  • Research Site

    Secundrabad, India

  • Research Site

    Vadodara, India

  • Research Site

    Sabah Al Salem, Kuwait

  • Research Site

    Muscat, Oman

  • Research Site

    Doha, Qatar

  • Research Site

    Jeddah, Saudi Arabia

  • Research Site

    Riyadh, Saudi Arabia

  • Research Site

    Abu Dhabi, United Arab Emirates

  • Research Site

    Al Ain City, United Arab Emirates

  • Research Site

    Dubai, United Arab Emirates

Conditions

Explore the condition pages connected to this study.